126
Participants
Start Date
December 31, 2012
Primary Completion Date
December 21, 2018
Study Completion Date
February 1, 2023
Chemotherapy
Treatment for all pathways consists of Induction, Intensification (where applicable), Consolidation and Maintenance therapy during which combination chemotherapy is given for up to 2.5 years.
Erasmus MC, Rotterdam
NHS Lanarkshire - Monklands, Airdrie
Blackpool Victoria Hopsital, Blackpool
Royal Bournemouth Hospital, Bournemouth
Bradford Royal Infirmary, Bradford
Bristol Haematology and Oncology Centre, Bristol
University Hospital of Wales, Cardiff
Castle Hill Hospital, Cottingham
Russells Hall Hospital, Dudley
Ninewells Hospital, Dundee
NHS Lothian - Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
New Victoria Hospital and Southern General Hospital, Glasgow
Northwick Park Hospital, Harrow
St James' Hospital, Leeds, Leeds
Leicester Royal Infirmary, Leicester
Royal Liverpool University Hospital, Liverpool
King's College Hospital NHS Foundation Trust, London
St Bartholomew's Hospital, London
St George's Hospital, London
The Christie Hospital, Manchester
Arrowe Park Hospital, Metropolitan Borough of Wirral
James Cook University Hospital, Middlesbrough
Churchill Hospital, Oxford, Oxford
Derriford Hospital, Plymouth
Poole General Hospital, Poole
St Helen's & Knowlsey Teaching Hospitals, Prescot
Salisbury District Hospital, Salisbury
Royal Hallamshire Hospital, Sheffield
Royal MarsdenHospital, Sutton
Great Western Hospital, Swindon
Musgrove Park, Taunton
Torbay Hospital, Torquay
Sandwell General Hospital, West Bromwich
Collaborators (1)
Cancer Research UK
OTHER
Stichting Hemato-Oncologie voor Volwassenen Nederland
OTHER
University College, London
OTHER